Loading data for ACON — first visit, this takes a few seconds.
Aclarion Inc. (ACON)
NasdaqCM: ACON
· Echtzeitkurs · USD
2.77
+0.17 (6.54%)
Zum Schluss: Aug 19, 2026, 8:00 PM
Aclarion Inc. (ACON) Stock Price, Analysis & Data
6.54% (1D)
Keine Daten verfügbar
| Geld | 2 |
| Marktkapitalisierung | 7.98 Mio |
| Umsatz (TTM) | 83.77K |
| Nettogewinn (TTM) | -9.2 Mio |
| Beta | 1.22 |
| EPS (ttm) | -7.42 |
| KGV (TTM) | n/a |
| Forward-KGV | -0.51 |
| KBV (TTM) | 0.40 |
| KUV (TTM) | 95.31 |
| Earnings Date | n/a |
| Brief | 3.3 |
| Volumen | 124,699 |
| Ø Vol. (20D) | 73,087 |
| Eröffnung | 2.70 |
| Vortagesschluss | 2.60 |
| Tagesspanne | 2.53 - 2.79 |
| 52-Wk Range | 1.95 - 12.03 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über ACON
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercial...
Branche Health Information Services
Sektor Healthcare
IPO Datum Apr 22, 2022
Mitarbeiter 10
Börse NasdaqCM
Tickersymbol ACON
Website https://www.aclarion.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Aclarion 75.73K, ein Anstieg von 65.62% im Vergleich zum Vorjahr (45.72K). Der Gewinn lag bei -7.23 Mio, ein Anstieg von 3.44 %.
Finanzberichte